CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

103 hedge funds and large institutions have $44.5M invested in Carisma Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

24% less call options, than puts

Call options by funds: $2.09M | Put options by funds: $2.75M

85% less capital invested

Capital invested by funds: $305M → $44.5M (-$261M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
103
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.09M
Puts
$2.75M
Net Calls
Net Calls Change

Top Buyers

1 +$1.35M
2 +$996K
3 +$563K
4
Jane Street
Jane Street
New York
+$512K
5
Morgan Stanley
Morgan Stanley
New York
+$367K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$253K
27
$175K
28
$161K
29
$152K
30
$137K
31
$122K
32
$113K
33
$104K
34
$97K
35
$91K
36
$86K
37
$82K
38
$79K
39
$76K
40
$73K
41
$69K
42
$69K
43
$66K
44
$63K
45
$62K
46
$60K
47
$58K
48
$58K
49
$54K
50
$54K